Search Results - T. M. Ripp

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Indap hypotensive efficacy, influence on cardiac structural and functional changes, and autoregulation of peripheral artery tonus by N. V. Belokopytova, V. F. Mordovin, T. M. Ripp

    Published 2004-04-01

    The aim of the study was to investigate indap hypotensive efficacy, its influence on cardiac structural and functional changes, as well as on vascular tonus autoregulation, among patients with essential arterial hypertension. The participants were 20 patients with essential hypertension, Stage I-II,...

    Full description

    Get full text
    Article
  2. 2

    Cerebrovascular Reserve Estimation by T. M. Ripp, E. G. Ripp, V. F. Mordovin

    Published 2010-12-01

    Estimation of the cerebrovascular reserve by transcranial ultrasound Doppler study on an original device and by physiological load tests may be used in cardiology, neurology, neurosurgery, and neuroreanimatology to evaluate cerebrovascular insufficiency and therapeutic effectiveness, to assess the r...

    Full description

    Get full text
    Article
  3. 3

    Indap hypotensive efficacy, influence on cardiac structural and functional changes, and autoregulation of peripheral artery tonus by N. V. Belokopytova, V. F. Mordovin, T. M. Ripp

    Published 2004-04-01

    The aim of the study was to investigate indap hypotensive efficacy, its influence on cardiac structural and functional changes, as well as on vascular tonus autoregulation, among patients with essential arterial hypertension. The participants were 20 patients with essential hypertension, Stage I-II,...

    Full description

    Get full text
    Article
  4. 4

    Cerebrovascular reactivity depending on rheumatoid factor and anticitrullinated protein antibody positivity in hypertensive patients with rheumatoid arthritis by N. V. Rebrova, O. L. Sarkisova, T. M. Ripp, R. S. Karpov, V. F. Mordovin

    Published 2022-07-01

    Objective – to investigate cerebrovascular reactivity (CVR) depending on rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA) positivity in hypertensive patients with rheumatoid arthritis (RA).Subjects and methods. A single cross-sectional study included 61 patients (mean age 59.8±7...

    Full description

    Get full text
    Article
  5. 5

    DYNAMICS OF GLYCEMIC CONTROL AFTER RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS by A. Yu. Falkovskaya, V. F. Mordovin, S. Ye. Pekarsky, A. Ye. Bayev, G. V. Semke, T. M. Ripp, Ye. S. Kravtchenko, I. V. Zyubanova

    Published 2015-10-01

    The aim of the study was to evaluatetheglycemic control dynamics depending on degree of blood pressure (BP) reduction and dynamic of TNF-α after 6 and 12 months of Tran catheter renal denervation (TRD) of patients with true resistant hypertension (RH) and type 2 diabetes mellitus (T2DM). Material an...

    Full description

    Get full text
    Article
  6. 6

    Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-up by E. S. Sitkova, V. F. Mordovin, S. E. Pekarskiy, T. M. Ripp, T. R. Ryabova, А. Yu. Falkovskaya, V. A. Lichikaki, I. V. Zyubanova, A. Е. Baev, A. M. Gusakova

    Published 2021-03-01

    Aim. To study the long-term effect of renal denervation (RDN) on left ventricular mass (LVM) and inflammatory markers in resistant hypertensive patients.Material and methods. Forty-one patients with resistant hypertension and 24-h blood pressure (BP) 158,7±15,8/87,3+14,6 mmHg, aged 56,6+10,2 years,...

    Full description

    Get full text
    Article
  7. 7

    Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up by I. V. Zyubanova, V. F. Mordovin, A. Yu. Falkovskaya, S. E. Pekarsky, T. M. Ripp, M. A. Manukyan, V. A. Lichikaki, A. M. Gusakova, T. R. Ryabova, A. E. Baev

    Published 2021-05-01

    Aim. To study the long-term outcomes of renal denervation (RDN) within 3-year follow-up with an assessment of blood pressure (BP) changes, the severity of target organ damage and the levels of pro- and anti-inflammatory cytokines in patients with resistant hypertension (RH), taking into account sex...

    Full description

    Get full text
    Article
  8. 8

    Distal renal denervation: cardioprotection in patients with resistant hypertension by E. S. Sitkova, V. F. Mordovin, S. E. Pekarsky, T. M. Ripp, A. Yu. Falkovskaya, V. A. Lichikaki, I. V. Zyubanova, A. E. Baev, T. R. Ryabova, O. V. Mochula, V. Yu. Usov

    Published 2020-09-01

    Aim. To study the effectiveness of using the anatomically optimized distal renal denervation (RDN) in comparison with the standard approach for reducing myocardial damage and left ventricular (LV) hypertrophy in patients with resistant hypertension (HTN).Material and methods. The randomized double-b...

    Full description

    Get full text
    Article
  9. 9

    Comparative analysis of cardioprotective effects of two renal denervation techniques by T. M. Ripp, S. E. Pekarskiy, A. E. Baev, T. R. Ryabova, E. I. Yaroslavskay, A. Yu. Falkovskaya, E. S. Sitkova, V. A. Lichikaki, I. V. Zubanova, M. A. Manukian, L. I. Gapon, V. F. Mordovin

    Published 2020-12-01

    Aim. To compare cardioprotective effects of two renal denervation (RD) techniques: main renal artery or its branches after bifurcation in patients with resistant hypertension (RH).Materials and methods. This randomized double-blind clinical (ClinicalTrials. gov. identifier: NCT02667912) study with a...

    Full description

    Get full text
    Article
  10. 10
  11. 11